Trimurthi Drugs & Pharmaceuticals board approves fund raising

Novelix Pharmaceuticals Ltd. | Trading | Miscellaneous | BSE: 536565 | NSE:

23 Jul 2012 Evaluate

Trimurthi Drugs & Pharmaceuticals has informed that the board of directors of the company at its meeting held on July 21, 2012, has considered and approved the raising of funds by issue of convertible warrants subject to approval of shareholders in ensuing annual general meeting and after detailed discussion, recommended the dividend of 3% on the equity shares for the year 2011-12.

The above information is a part of company's filings submitted to BSE.

Peers

Company Name	CMP
Redington	407.25
Adani Enterprises	2914.95
Amrapali Industries	38.40
Rashi Peripheral	899.00
ABans Enterprises	27.40
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.